An influential Institute of Medicine advisory panel co-chaired by Dr. Sheldon Greenfield, the Donald Bren Professor of Medicine at UC Irvine, has issued a report urging the U.S. government to fund studies comparing treatments for Alzheimer’s disease, attention deficit disorder and other conditions to determine which strategies work best. The recommendations were included in a list of 100 priorities developed by the panel, which was charged with advising the government on how to spend money allocated by Congress for “comparative effectiveness” research. “This report lays the foundation for an ongoing enterprise to provide the evidence that healthcare providers need to make better decisions and achieve better results,” Greenfield said.